<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药投资并购俱乐部 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-20T20:49:14+08:00</updated>
  <subtitle>healthib俱乐部是医药医疗健康领域企业家与投资人的资源共享与价值共创的非营利性公众学习平台，专注于投资并购与产业整合资源的分享和学习，感谢您的关注！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年中国AI+医疗行业报告</title>
    <updated>2021-01-20T13:45:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/9EpESsOlFEqKxhmAGaFYvA</id>
    <link href="https://mp.weixin.qq.com/s/9EpESsOlFEqKxhmAGaFYvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国血管造影设备行业概览</title>
    <updated>2021-01-19T17:24:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/ZDuzLm-aM1aab-iSoohD-w</id>
    <link href="https://mp.weixin.qq.com/s/ZDuzLm-aM1aab-iSoohD-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人类白血病自噬研究现状展望：肿瘤干细胞和耐药性的敌人，新治疗干预的朋友（上）</title>
    <updated>2021-01-18T17:49:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/ONIK9TDrFnHi4s2Zn9vAiQ</id>
    <link href="https://mp.weixin.qq.com/s/ONIK9TDrFnHi4s2Zn9vAiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年血液制品批签发总结（2021-01-14）</title>
    <updated>2021-01-15T16:29:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/DTHJS0gZZ3o_lfVOWGkD5Q</id>
    <link href="https://mp.weixin.qq.com/s/DTHJS0gZZ3o_lfVOWGkD5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年疫苗批签发总结：后疫情时代，疫苗行业迎来新机遇</title>
    <updated>2021-01-14T16:27:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/sVfCC015jpel4bbq3W84Ig</id>
    <link href="https://mp.weixin.qq.com/s/sVfCC015jpel4bbq3W84Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年疫苗行业批签发专题报告：大品种持续放量，行业持续高景气</title>
    <updated>2021-01-13T14:17:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/YyBZ7W5rSpIAzaMHCbtB_g</id>
    <link href="https://mp.weixin.qq.com/s/YyBZ7W5rSpIAzaMHCbtB_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医美机构专题：区域龙头奋楫扬帆，星辰大海未来已来</title>
    <updated>2021-01-12T11:42:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/c68t_n_JDc7r-fpGa6i_Bw</id>
    <link href="https://mp.weixin.qq.com/s/c68t_n_JDc7r-fpGa6i_Bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药行业周报：医药“核心50”资产外，哪些品种可以配？</title>
    <updated>2021-01-11T15:44:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/bV1-iW-OXOTuSIhCKXkmXw</id>
    <link href="https://mp.weixin.qq.com/s/bV1-iW-OXOTuSIhCKXkmXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药行业2021年度策略，后疫情时代，医药发展新动力</title>
    <updated>2021-01-08T16:05:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Yp8Y_VU1xnS42QY3ZZpQJg</id>
    <link href="https://mp.weixin.qq.com/s/Yp8Y_VU1xnS42QY3ZZpQJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药生物：医改政策加速推进，行业创新提速</title>
    <updated>2021-01-07T17:05:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/CVPUToma-6MHw7vzgiCXTw</id>
    <link href="https://mp.weixin.qq.com/s/CVPUToma-6MHw7vzgiCXTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>